Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the ...

Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an ...

The Dow Jones industrials still held a loss of 0.3% after the index pared a steeper loss. Blue-chip stocks like Nvidia NVDA, ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.

A new drug delivery method could improve treatments for inflammatory bowel disease (IBD) like ulcerative colitis and Crohn’s disease. Currently available oral drugs for IBD must transit the entire ...

Spherix Global Insights surveyed 103 gastroenterologists on their thoughts on the ulcerative colitis prescription market. 1. The providers projected significant growth for Takeda’s Entyvio, Janssen’s ...

For the third straight quarter, AbbVie has jacked up its revenue forecast for 2025. The Illinois drugmaker has raised its guidance by $400 million, now expecting sales to reach $60.9 billion. | ...

ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new ...